Therapeutic Drug Monitoring of Tumor Necrosis Factor Antagonists in Crohn Disease: A Theoretical Construct to Apply Pharmacokinetics and Guidelines to Clinical Practice

Therapeutic drug monitoring (TDM) is the measurement of drug and antidrug antibody concentrations in individuals to guide treatment decisions. In patients with Crohn disease (CD), TDM, used either reactively or proactively, is emerging as a valuable tool for optimization of tumor necrosis factor (TN...

Descripción completa

Detalles Bibliográficos
Autores principales: Vande Casteele, Niels, Feagan, Brian G, Wolf, Douglas C, Pop, Anca, Yassine, Mohamed, Horst, Sara N, Ritter, Timothy E, Sandborn, William J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Review Article - Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314098/
https://www.ncbi.nlm.nih.gov/pubmed/33051647
http://dx.doi.org/10.1093/ibd/izaa265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314098/
https://www.ncbi.nlm.nih.gov/pubmed/33051647
http://dx.doi.org/10.1093/ibd/izaa265

Ejemplares similares